Jeffrey W Taub

18PUBLICATIONS
101CO-AUTHORS
Medical virologyHaematological tumoursMolecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 21, 2026
The effect of cohesin mutations on HLA-class II expression in the myeloid leukemia of Down syndrome.

|May 13, 2026
Development and Characterization of a Novel Congenital Acute Erythroid Leukemia Cell Line with Unique Features.

|Jan 28, 2026
Enhancing the Nucleoside Analog Response with Translational Therapeutic Approaches to Overcome Resistance.

Jenna Thibodeau, Kian Hershberger, Sai Samanvitha M Ramakrishna

|Oct 22, 2025
Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease.

Jason N Berman, Anupam Verma, Shelton Viola

|Sep 16, 2025
Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine.

Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi

|Aug 09, 2024
The evolution and history of Vinca alkaloids: From the Big Bang to the treatment of pediatric acute leukemia.

Jeffrey W Taub, Steven A Buck, Ana C Xavier

Pageof 3

Frequent Collaborators

7 joint publications

Yubin Ge

3 joint publications

Johann K Hitzler

2 joint publications

Shondra M Pruett-Miller

2 joint publications

Reuven Schore